Marc Geirnaert
5PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 07, 2025
Analysis of real-world safety, tolerability, and cost efficiency of Sub-Cutaneous administration of Daratumumab in Manitoba.Kaitlin Quinlan, Marc Geirnaert, Rami Kotb
|Dec 27, 2022
An overview of the role of selpercatinib and pralsetinib in RET-fusion-positive non-small cell lung cancer (NSCLC).Vanessa Quang Nguyen, Marc Geirnaert
|Apr 06, 2022
International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions.Andrew Walker, Alexandre Chan, Constanza Cortés Labra
|Oct 28, 2020
A multicenter review of infusion-related reactions to daratumumab for relapsed multiple myeloma in the real world setting.Marc Geirnaert, Jacy Howarth, Kristen Martin
|Jul 31, 2020
Off-label infusion of biosimilar bevacizumab: A provincial experience.Marc Geirnaert, Jacy Howarth, Curtis Kellett
Pageof 1
